[1]
Muhammad Murtaza Shafqat, Ali Raza Naqvi, Amir Shafique, Rashid Ali Khosa, Shabeer Ahmed, Hazar Khan Bugti, “Ryzodeg (Insulin Degludec/Aspart) for Type 2 Diabetes in Pakistan: A 12-Week Study on Glycemic Control and Safety Outcomes”, Pakistan Journal of Medical & Health Sciences, vol. 16, no. 09, p. 1003, Sep. 2022.